These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Medicamentous strategy for improving the quality of life in the senescence]. Knoll J. Wien Med Wochenschr Suppl; 1986; 98():1-18. PubMed ID: 3097965 [Abstract] [Full Text] [Related]
3. Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease. Melamed E. Adv Neurol; 1990; 53():61-6. PubMed ID: 2173376 [No Abstract] [Full Text] [Related]
4. Are "on-off" effects during chronic L-dopa treatment due to faulty feedback control of the nigrostriatal dopamine pathway? Carlsson A. J Neural Transm Suppl; 1983; 19():153-61. PubMed ID: 6321646 [Abstract] [Full Text] [Related]
10. Indirect evidence for a feedback loop mechanism between two central dopaminergic pathways: preliminary results. Yehuda S. Commun Psychopharmacol; 1979; 3(2):115-9. PubMed ID: 467002 [No Abstract] [Full Text] [Related]
12. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa. Brannan T, Knott P, Kaufmann H, Yahr M. Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378 [No Abstract] [Full Text] [Related]